Oramed Pharmaceuticals Stock (NASDAQ: ORMP)

Oramed Pharmaceuticals Stock (NASDAQ:ORMP), Trade Ideas

Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

News

Penny Stocks

Short Ideas

Small Cap

Pre-Market Outlook

Markets

Trading Ideas

CALC

FGEN

ORMP

PEPG

As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 4 Health Care Stocks That May Crash This Quarter

Intraday Update

Movers

APLD

APOG

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BBLN

BDRX

BFRI

CFMS

CRCT

FOXO

GSRM

HAIN

KITT

LCUT

LFLY

MEDS

NVVE

ONCS

PIRS

SKLZ

SONN

SPCE

SRGA

SRPT

SWBI

TMPO

TRUP

WORX

XAIR

Gainers


	Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie &#39;World&#39;s Best&#39;.


Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

GRNQ

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.

Following the market opening Friday, the Dow traded down 0.74% to 33,695.28 while the NASDAQ fell 0.98% to 13,497.22. The S&amp;P 500, also fell, dropping, 0.78% to 4,347.58.

Dow Tumbles 250 Points; CarMax Posts Upbeat Results

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals, Inc. (ORMP) is higher by Friday morning, with the stock climbing 5.95% in pre-market trading to 2.85. ORMP's short-term technical score of 50 indicates that the stock has traded as bullishly as over the last month than 50% of stocks on the market. In the Biotechnology industry, which ranks 119 out o

Should You Accumulate Oramed Pharmaceuticals, Inc. (ORMP) Stock Friday Morning?

Oramed Pharmaceuticals, Inc. (ORMP) is up 6.67% today. ORMP has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on ORMP!See Full ORMP ReportORMP stock closed at $2.85 and is up $0.19 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as

Oramed Pharmaceuticals, Inc. (ORMP) has risen 6.67% Monday In Premarket Trading

MQ, ORMP and EXAI are among pre market gainers

Oramed Pharmaceuticals, Inc. (ORMP) is down -4.14%% today. ORMP has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on ORMP!See Full ORMP ReportORMP stock closed at $3.14 and is down -$0.13 during pre-market trading. Pre-market tends to be more volatile due to significantly lower vo

Oramed Pharmaceuticals, Inc. (ORMP) is down 4.14% Tuesday In Premarket Trading

Oramed Pharmaceuticals (ORMP) has released an update. Oramed Pharmaceuticals Inc. has shared a letter to its shareholders from CEO Nadav Kidron thr...

Oramed Pharmaceuticals CEO Updates Shareholders on Strategy

Oramed Pharmaceuticals, Inc. (ORMP) has gained Thursday morning, with the stock climbing 11.21% in pre-market trading to 3.57. ORMP's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 109 out o

Oramed Pharmaceuticals, Inc. (ORMP) is up 11.21% Thursday In Premarket Trading

Oramed Pharmaceuticals, Inc. (ORMP) is down -3.99%% today. ORMP has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on ORMP!See Full ORMP ReportORMP stock closed at $3.26 and is down -$0.13 during pre-market trading. Pre-market tends to be more volatile due to significantly lower vo

Oramed Pharmaceuticals, Inc. (ORMP) is down 3.99% Wednesday In Premarket Trading

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Oramed Pharmaceuticals</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/ormp-stock-quote/"><strong>ORMP</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Oramed Pharmaceuticals reported earnings per share of 33 cents. This was above the analyst estimate for EPS of -12 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/03/ormp-stock-earnings-oramed-pharmaceuticals-for-q4-of-2023/">ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q4 2023

The latest announcement is out from Oramed Pharmaceuticals (ORMP). Oramed Pharmaceuticals Inc. has announced the appointment of Mr. Yehuda Reznick ...

Oramed Pharmaceuticals Welcomes New Audit Committee Chair

Oramed Pharmaceuticals (ORMP) has shared an update. Oramed Pharmaceuticals Inc. has initiated an agreement with Rodman & Renshaw LLC and StockBlock...

Oramed Pharmaceuticals Updates Stock Sale Strategies and Partners

CAUD

DHAI

EXAI

GROY

INGN

LUNR

MGIH

PRSO

PTPI

Press Releases

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

Oramed to Present at the 83rd American Diabetes Association Conference

Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally

Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder

Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.

Contracts

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company

Opinion

Thinking about buying stock in MicroAlgo, Oramed Pharmaceuticals, Limbach Holdings, Niu Technologies, or Applied Molecular Transport?

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

Oramed Letter to Shareholders

Health Care

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation